HLA-DPB1 and sclerosing cholangitis: The interaction of DPB1 with NKp44 has been reported as a risk factor for both primary sclerosing cholangitis, an immune-mediated liver disease, and ulcerative colitis, a form of inflammatory bowel disease (164, 165).